“…Target cell availability is probably maximal for NK cells in blood borne cancers, hence, we believe that these diseases will show the highest CD45RARO NK cell numbers; although these cells are unable to control the disease. Leukemogenesis in mouse is enhanced when the host immune system is impaired ( Garaude et al, 2008 , Kaminski et al, 2012 ) and more hematological cancer patients present severe NK cell dysfunctions ( Baier et al, 2013 ). Others and we have shown the requirement of fully functional NK cells to eradicate blood-borne tumors in several mouse models ( Karre et al, 1986 , Van Den Broek et al, 1995 , Pardo et al, 2002 , Aguilo et al, 2009 , Charni et al, 2009 , Charni et al, 2010 , Ramírez-Comet et al, 2014 ).…”